Salix Pharmaceuticals
Salix Pharmaceuticals is a leading specialty pharmaceutical company dedicated to the prevention and treatment of gastrointestinal diseases and disorders. With over 30 years of experience, the company focuses on constant innovation to improve patients' lives and provides healthcare professionals with effective treatment options across various GI conditions. Salix emphasizes ethical standards, community engagement, and fostering meaningful relationships with healthcare providers and patients. It is committed to discovery, comprehensive practice support, and making a difference in GI healthcare.
Industries
Nr. of Employees
large (251-1000)
Salix Pharmaceuticals
400 Somerset Corporate Blvd., Bridgewater, NJ 08807
Patents
Products
Xifaxan (rifaximin) 200 mg and 550 mg tablets
Oral antibiotic indicated for specific gastrointestinal conditions (listed formulations include 200 mg and 550 mg tablets).
Plenvu (PEG-based bowel preparation)
1‑liter polyethylene glycol (PEG)-based oral bowel cleansing preparation supplied as multi-dose pouches for colonoscopy preparation.
Relistor (methylnaltrexone bromide) – injection and oral tablets
Peripherally acting opioid antagonist available as subcutaneous injection and oral tablets for opioid‑induced constipation indications.
Trulance (plecanatide) 3 mg tablets
Oral tablet indicated for certain constipation-related indications.
Uceris (budesonide) – rectal foam and extended‑release tablets
Topical rectal foam and oral extended‑release tablet formulations of budesonide used for inflammatory bowel disease indications.
MoviPrep (PEG-based oral solution)
Polyethylene glycol-based oral solution bowel preparation for colonoscopy.
Xifaxan (rifaximin) 200 mg and 550 mg tablets
Oral antibiotic indicated for specific gastrointestinal conditions (listed formulations include 200 mg and 550 mg tablets).
Plenvu (PEG-based bowel preparation)
1‑liter polyethylene glycol (PEG)-based oral bowel cleansing preparation supplied as multi-dose pouches for colonoscopy preparation.
Relistor (methylnaltrexone bromide) – injection and oral tablets
Peripherally acting opioid antagonist available as subcutaneous injection and oral tablets for opioid‑induced constipation indications.
Trulance (plecanatide) 3 mg tablets
Oral tablet indicated for certain constipation-related indications.
Uceris (budesonide) – rectal foam and extended‑release tablets
Topical rectal foam and oral extended‑release tablet formulations of budesonide used for inflammatory bowel disease indications.
MoviPrep (PEG-based oral solution)
Polyethylene glycol-based oral solution bowel preparation for colonoscopy.
Services
Programs to assist patient access to medications, including copay savings and an established patient assistance application process.
Online form and fulfillment process for HCPs to request product literature and clinical information.
Submission channel for medical and clinical inquiries related to products.
Annual scholarship program providing financial awards to students living with gastrointestinal diseases and disorders.
Programs to assist patient access to medications, including copay savings and an established patient assistance application process.
Online form and fulfillment process for HCPs to request product literature and clinical information.
Submission channel for medical and clinical inquiries related to products.
Annual scholarship program providing financial awards to students living with gastrointestinal diseases and disorders.
Expertise Areas
- Gastrointestinal therapeutics
- Clinical development and data dissemination
- Regulatory strategy and submissions
- Pharmaceutical formulation and drug delivery
Key Technologies
- Microbiome research methods
- PEG-based oral bowel preparation formulation
- Extended-release oral tablet technology
- Rectal foam and topical formulation technology